BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anastassiou, G.
Right arrow Articles by Steuhl, K.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anastassiou, G.
Right arrow Articles by Steuhl, K.-P.
British Journal of Ophthalmology 2002;86:163-167
© 2002 British Journal of Ophthalmology


CLINICAL SCIENCE

Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study

Gerasimos Anastassiou1, Arnd Heiligenhaus2, Nikos Bechrakis3, Elisabeth Bader1, Norbert Bornfeld1, Klaus-Peter Steuhl1

1 Department of Ophthalmology, University Hospital Essen, University of Essen, Germany
2 Department of Ophthalmology, St Franziskus Hospital, Muenster, Germany
3 Department of Ophthalmology, UKBF, Free University, Berlin, Germany

Correspondence to:
Correspondence to:
Dr G Anastassiou, Department of Ophthalmology, University of Essen, Hufelandstrasse 55, D-45122 Essen, Germany;
gerasimos.anastassion{at}uni-essen.de

Aim: To determine prognostic factors for recurrence of disease and tumour related mortality in patients with conjunctival melanoma.

Methods: A retrospective analysis of clinical and histopathological data of 69 patients with histologically verified conjunctival melanoma.

Results: As univariate analysis showed, significant risk factors for the development of recurrence were: irregular pigmentation (RR = 2.0, p = 0.0007), incomplete surgical excision (RR = 3.5, p = 0.008), tumour invasion deeper than in substantia propria (RR = 3.9, p = 0.008), and presence of epithelioid tumour cells (RR = 2.9, p = 0.05). For tumour related mortality a significantly increased risk was found for tumour location in palpebral conjunctiva, caruncle, plica, or fornices (RR = 5.9, p = 0.001), for tumour infiltration deeper than the substantia propria (RR = 5.5, p = 0.001), for incomplete surgical excision (RR = 4.4, p = 0.05), and for nodular or mixed (nodular and superficial) growth pattern of the tumours (RR = 1.2, p = 0.002). The use of an adjuvant therapy for the surgical excision of the melanomas had no statistically significant influence upon the development of recurrent disease nor upon the tumour related mortality.

Conclusion: These data present similar clinical and histopathological risk factors for patients with conjunctival melanoma as reported previously. The present study also addresses the failure of retrospective studies on conjunctival melanoma to prove the efficacy of a supplementary therapy to surgical excision.





This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
B Damato and S E Coupland
Clinical mapping of conjunctival melanomas
Br. J. Ophthalmol., November 1, 2008; 92(11): 1545 - 1549.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
M Lim, T Tatla, D Hersh, and J Hungerford
Patterns of regional head and neck lymph node metastasis in primary conjunctival malignant melanoma
Br. J. Ophthalmol., December 1, 2006; 90(12): 1468 - 1471.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
G. S. Missotten, S. Keijser, R. J. W. De Keizer, and D. De Wolff-Rouendaal
Conjunctival Melanoma in The Netherlands: A Nationwide Study
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 75 - 82.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Gear, H. Williams, E. G. Kemp, and F. Roberts
BRAF Mutations in Conjunctival Melanoma
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2484 - 2488.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd.